CD BioGlyco offers comprehensive solutions related to marine glycan that cover Marine Biomolecule Production Services, Marine Carbohydrate-based Vaccines Development Services, and Marine Carbohydrate-based Adjuvant Development Services. Our team of skilled scientists is highly proficient in delivering customized services in the field of Sargassum pallidum polysaccharide adjuvant development.
We dissolve Sargassum pallidum polysaccharides in a suitable solvent, such as water or saline, to form a stable solution. Its biological activities including antioxidant, anti-inflammatory, and immunomodulatory, are evaluated by in vitro and in vivo experiments.
We select appropriate gelling or cross-linking agents to convert Sargassum pallidum polysaccharides into a gel state. The gelators we usually use include gelatin and sodium alginate, and the commonly used cross-linking agents include aluminum sulfate and ethylene glycol dimethylpropane. Subsequently, we evaluate the temperature stability, drug compatibility, and mechanical stability, and then they are characterized by using scanning electron microscopy and transmission electron microscopy. We then regulate the rate and mode of drug release to meet the drug delivery requirements. Finally, we evaluate the biocompatibility of the products, which includes cytotoxicity tests, in vivo and in vitro tests in animals.
Fig.1 Process of Sargassum pallidum polysaccharide adjuvant development. (CD BioGlyco)
Technology: Polysaccharide extraction and immunological efficacy assessment techniques
Journal: Marine Drugs
IF: 5.4
Published: 2012
Results: This paper investigated the effect of Sargassum pallidum polysaccharide as an adjuvant on the immune activity of three poultry vaccines. The authors added Sargassum pallidum polysaccharide to three vaccines, namely Newcastle disease, infectious bronchitis, and avian influenza, and evaluated the adjuvant effect of the polysaccharide by measuring the immunity indexes of the poultry after vaccination. The results showed that the addition of Sargassum pallidum polysaccharide significantly improved the immunization effect of the three vaccines. In the Newcastle disease vaccine, the polysaccharide group showed a 1.5-fold increase in antibody titer compared with the control group. In the infectious bronchitis vaccine and avian influenza vaccine, the polysaccharide group showed an enhancement in cellular immune response and antibody titer compared with the control group. The authors also evaluated the in vivo toxicity of the polysaccharides and showed that Sargassum pallidum polysaccharides had no significant toxic side effects in poultry. Therefore, the study suggests that Sargassum pallidum polysaccharide is effective in poultry vaccine research and has a promising application.
Fig.2 Anticancer activity of seaweed polysaccharide. (Nigam, et al., 2022)
The application of Sargassum pallidum polysaccharide as an adjuvant in biopharmaceutical and glycomedical research requires in-depth studies of its structure and function. CD BioGlyco is well-positioned to provide expertise and services in the development of Sargassum pallidum polysaccharide adjuvant. Please
if you have any questions regarding our services.References